Literature DB >> 11479510

Endothelin-1 during and after cardiopulmonary bypass: association to graft sensitivity and postoperative recovery.

B R Bond1, B H Dorman, M J Clair, C A Walker, M L Pinosky, S T Reeves, S Walton, J M Kratz, J L Zellner, A J Crumbley, M M Multani, F G Spinale.   

Abstract

OBJECTIVE: Our objectives are 2-fold: (1) to serially measure the release of endothelin and graft-conduit endothelin sensitivity during and after coronary artery bypass grafting and (2) to define potential relationships of changes in endothelin levels to perioperative parameters.
METHODS: Endothelin plasma content was measured in patients (n = 105) undergoing bypass grafting from select vascular compartments before operations and at specific intervals up to 24 hours postoperatively. Endothelin sensitivity was determined in isolated internal thoracic artery segments.
RESULTS: Systemic arterial and pulmonary arterial endothelin levels were increased by approximately 50% immediately after bypass grafting and increased by another 85% during the first 24 hours postoperatively. Endothelin levels were highest in patients with prolonged ventilatory requirements and extended stays in the intensive care unit (10.2 +/- 0.8 vs 13.2 +/- 1.1 fmol/mL, P =.02, and 9.8 +/- 0.7 vs 13.9 +/- 1.2 fmol/mL, P =.01, respectively. Endothelin sensitivity of the internal thoracic artery was increased in patients requiring prolonged vasodilator support with nitroglycerin.
CONCLUSIONS: Systemic and pulmonary arterial endothelin levels remained increased for at least 24 hours postoperatively. Prolonged pharmacologic management and increased intensive care unit stay were associated with increased systemic endothelin release and heightened graft-conduit sensitivity to endothelin.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11479510     DOI: 10.1067/mtc.2001.114936

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  8 in total

1.  Effects of cardiopulmonary bypass on endothelin-1-induced contraction and signaling in human skeletal muscle microcirculation.

Authors:  Jun Feng; Louis M Chu; Michael P Robich; Richard T Clements; Kamal R Khabbaz; Robert Hagberg; Yuhong Liu; Robert M Osipov; Frank W Sellke
Journal:  Circulation       Date:  2010-09-14       Impact factor: 29.690

2.  Endothelin-A receptor inhibition after cardiopulmonary bypass: cytokines and receptor activation.

Authors:  Rachael L Ford; Ira M Mains; Ebony J Hilton; Scott T Reeves; Robert E Stroud; Fred A Crawford; John S Ikonomidis; Francis G Spinale
Journal:  Ann Thorac Surg       Date:  2008-11       Impact factor: 4.330

3.  Endothelin-1-induced contractile responses of human coronary arterioles via endothelin-A receptors and PKC-alpha signaling pathways.

Authors:  Jun Feng; Yuhong Liu; Kamal R Khabbaz; Robert Hagberg; Neel R Sodha; Robert M Osipov; Frank W Sellke
Journal:  Surgery       Date:  2010-01-15       Impact factor: 3.982

4.  Selective endothelin-1 receptor type A inhibition in subjects undergoing cardiac surgery with preexisting left ventricular dysfunction: Influence on early postoperative hemodynamics.

Authors:  John M Toole; John S Ikonomidis; Wilson Y Szeto; James L Zellner; John Mulcahy; Rachael L Deardorff; Francis G Spinale
Journal:  J Thorac Cardiovasc Surg       Date:  2010-01-13       Impact factor: 5.209

5.  Right ventricular function declines after cardiac surgery in adult patients with congenital heart disease.

Authors:  Mark J Schuuring; Pauline P M Bolmers; Barbara J M Mulder; Rianne A C M de Bruin-Bon; Dave R Koolbergen; Mark G Hazekamp; Wim K Lagrand; Stefan G De Hert; E M F H de Beaumont; Berto J Bouma
Journal:  Int J Cardiovasc Imaging       Date:  2011-06-03       Impact factor: 2.357

6.  A multicentre randomized-controlled trial of inhaled milrinone in high-risk cardiac surgical patients.

Authors:  André Y Denault; Jean S Bussières; Ramiro Arellano; Barry Finegan; Paul Gavra; François Haddad; Anne Q N Nguyen; France Varin; Annik Fortier; Sylvie Levesque; Yanfen Shi; Mahsa Elmi-Sarabi; Jean-Claude Tardif; Louis P Perrault; Jean Lambert
Journal:  Can J Anaesth       Date:  2016-07-28       Impact factor: 6.713

7.  Advanced therapy for pulmonary arterial hypertension due to congenital heart disease: a clinical perspective in a new therapeutic era.

Authors:  M J Schuuring; S M Boekholdt; A Windhausen; B J Bouma; M Groenink; M Keijzers; R J De Winter; D R Koolbergen; N A Blom; B J M Mulder
Journal:  Neth Heart J       Date:  2011-12       Impact factor: 2.380

8.  Preoperative Serum GDF-15, Endothelin-1 Levels, and Intraoperative Factors as Short-Term Operative Risks for Patients Undergoing Cardiovascular Surgery.

Authors:  Takashi Kato; Toshiaki Nakajima; Taira Fukuda; Ikuko Shibasaki; Takaaki Hasegawa; Koji Ogata; Hironaga Ogawa; Shotaro Hirota; Hirotaka Ohashi; Shunsuke Saito; Yusuke Takei; Masahiro Tezuka; Masahiro Seki; Toshiyuki Kuwata; Masashi Sakuma; Shichiro Abe; Shigeru Toyoda; Teruo Inoue; Hirotsugu Fukuda
Journal:  J Clin Med       Date:  2021-05-02       Impact factor: 4.241

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.